148 related articles for article (PubMed ID: 8484504)
1. Human alfentanil metabolism by cytochrome P450 3A3/4. An explanation for the interindividual variability in alfentanil clearance?
Kharasch ED; Thummel KE
Anesth Analg; 1993 May; 76(5):1033-9. PubMed ID: 8484504
[TBL] [Abstract][Full Text] [Related]
2. The role of cytochrome P450 3A4 in alfentanil clearance. Implications for interindividual variability in disposition and perioperative drug interactions.
Kharasch ED; Russell M; Mautz D; Thummel KE; Kunze KL; Bowdle A; Cox K
Anesthesiology; 1997 Jul; 87(1):36-50. PubMed ID: 9232132
[TBL] [Abstract][Full Text] [Related]
3. Identification of cytochrome P450 2E1 as the predominant enzyme catalyzing human liver microsomal defluorination of sevoflurane, isoflurane, and methoxyflurane.
Kharasch ED; Thummel KE
Anesthesiology; 1993 Oct; 79(4):795-807. PubMed ID: 8214760
[TBL] [Abstract][Full Text] [Related]
4. Catalytic role of cytochrome P4503A4 in multiple pathways of alfentanil metabolism.
Labroo RB; Thummel KE; Kunze KL; Podoll T; Trager WF; Kharasch ED
Drug Metab Dispos; 1995 Apr; 23(4):490-6. PubMed ID: 7600917
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 enzymes involved in acetaminophen activation by rat and human liver microsomes and their kinetics.
Patten CJ; Thomas PE; Guy RL; Lee M; Gonzalez FJ; Guengerich FP; Yang CS
Chem Res Toxicol; 1993; 6(4):511-8. PubMed ID: 8374050
[TBL] [Abstract][Full Text] [Related]
6. Fentanyl metabolism by human hepatic and intestinal cytochrome P450 3A4: implications for interindividual variability in disposition, efficacy, and drug interactions.
Labroo RB; Paine MF; Thummel KE; Kharasch ED
Drug Metab Dispos; 1997 Sep; 25(9):1072-80. PubMed ID: 9311623
[TBL] [Abstract][Full Text] [Related]
7. Identification of the pharmacogenetic determinants of alfentanil metabolism: cytochrome P-450 3A4. An explanation of the variable elimination clearance.
Yun CH; Wood M; Wood AJ; Guengerich FP
Anesthesiology; 1992 Sep; 77(3):467-74. PubMed ID: 1519785
[TBL] [Abstract][Full Text] [Related]
8. Pharmacogenetic determinants of human liver microsomal alfentanil metabolism and the role of cytochrome P450 3A5.
Klees TM; Sheffels P; Thummel KE; Kharasch ED
Anesthesiology; 2005 Mar; 102(3):550-6. PubMed ID: 15731592
[TBL] [Abstract][Full Text] [Related]
9. Isoflurane: a comparison of its metabolism by human and rat hepatic cytochrome P-450.
Bradshaw JJ; Ivanetich KM
Anesth Analg; 1984 Sep; 63(9):805-13. PubMed ID: 6465574
[TBL] [Abstract][Full Text] [Related]
10. Induction of tamoxifen-4-hydroxylation by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD), beta-naphthoflavone (beta NF), and phenobarbital (PB) in avian liver: identification of P450 TCDDAA as catalyst of 4-hydroxylation induced by TCDD and beta NF.
Kupfer D; Mani C; Lee CA; Rifkind AB
Cancer Res; 1994 Jun; 54(12):3140-4. PubMed ID: 8205532
[TBL] [Abstract][Full Text] [Related]
11. Kinetic analysis of the activation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone by heterologously expressed human P450 enzymes and the effect of P450-specific chemical inhibitors on this activation in human liver microsomes.
Patten CJ; Smith TJ; Murphy SE; Wang MH; Lee J; Tynes RE; Koch P; Yang CS
Arch Biochem Biophys; 1996 Sep; 333(1):127-38. PubMed ID: 8806763
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 isozymes catalyzing 4-hydroxylation of parkinsonism-related compound 1,2,3,4-tetrahydroisoquinoline in rat liver microsomes.
Suzuki T; Fujita S; Narimatsu S; Masubuchi Y; Tachibana M; Ohta S; Hirobe M
FASEB J; 1992 Jan; 6(2):771-6. PubMed ID: 1537468
[TBL] [Abstract][Full Text] [Related]
13. Intraindividual variability in male hepatic CYP3A4 activity assessed by alfentanil and midazolam clearance.
Kharasch ED; Jubert C; Senn T; Bowdle TA; Thummel KE
J Clin Pharmacol; 1999 Jul; 39(7):664-9. PubMed ID: 10392320
[TBL] [Abstract][Full Text] [Related]
14. Hepatic cytochrome P450 induction in goats. Effects of model inducers on the metabolism of alkoxyresorufins, testosterone and ethylmorphine, and on apoprotein and mRNA levels.
van't Klooster GA; Horbach GJ; Natsuhori M; Blaauboer BJ; Noordhoek J; van Miert AS
Biochem Pharmacol; 1993 Jan; 45(1):113-22. PubMed ID: 8424805
[TBL] [Abstract][Full Text] [Related]
15. Human reductive halothane metabolism in vitro is catalyzed by cytochrome P450 2A6 and 3A4.
Spracklin DK; Thummel KE; Kharasch ED
Drug Metab Dispos; 1996 Sep; 24(9):976-83. PubMed ID: 8886607
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 catalyzed metabolism of 1,2-dibromoethane in liver microsomes of differentially induced rats.
Wormhoudt LW; Ploemen JH; Commandeur JN; van Ommen B; van Bladeren P; Vermeulen NP
Chem Biol Interact; 1996 Jan; 99(1-3):41-53. PubMed ID: 8620578
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of cyclosporine after orthotopic liver transplantation.
Fabre JM; Pedrosa R; Bonardet A; Pichard L; Descomps B; Domergue J; Baumel H; Maurel P
Biochem Pharmacol; 1993 Oct; 46(7):1151-7. PubMed ID: 8216365
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the stability and cytochrome P450 specificity of the phenobarbital-induced reductive halothane-cytochrome P450 complex formed in rat hepatic microsomes.
Baker MT; Vasquez MT; Chiang CK
Biochem Pharmacol; 1991 Jun; 41(11):1691-9. PubMed ID: 2043158
[TBL] [Abstract][Full Text] [Related]
19. Possible involvement of multiple cytochrome P450S in fentanyl and sufentanil metabolism as opposed to alfentanil.
Guitton J; Buronfosse T; Désage M; Lepape A; Brazier JL; Beaune P
Biochem Pharmacol; 1997 Jun; 53(11):1613-9. PubMed ID: 9264313
[TBL] [Abstract][Full Text] [Related]
20. Inactivation of chick embryo hepatic cytochrome P450 1A, 2H and 3A following in ovo administration of 3,5-diethoxycarbonyl-1,4-dihydro-2,6-dimethyl-4-ethylpyridine and 3-[2-(2,4,6-trimethylphenyl)thioethyl]-4-methylsydnone.
McNamee JP; Kimmett SM; Marks GS
Biochem Pharmacol; 1995 May; 49(10):1443-52. PubMed ID: 7763287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
